Stocks to watch for Tuesday, November 6 Abbott Labs (ABT) agreed to pay $3.7 billion for Kos Pharmaceuticals, which makes a drug that raises so-called good cholesterol. Activision (ATVI) reported fiscal second-quarter revenue of $188.2 million, down 15%

More...